Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Reckitt Benckiser Group Plc (OP:RBGPF)

69.00 +0.35 (+0.51%)
Streaming Delayed Price Updated: 10:05 AM EDT, Aug 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Reckitt Benckiser Group Plc

News headline image
FDA Wants To Pull Popular OTC Decongestant Used For Common Cold Over Effectiveness Concerns ↗
FDA proposes removing oral phenylephrine from OTC drugs for nasal congestion, citing ineffectiveness. Public comments open before a final order is issued. 
Via Benzinga
News headline image
Consumer Giant Reckitt Seeks Help From Investment Banks To Evaluate Options For Homecare Brands, Baby Formula ↗
Reckitt Benckiser is reportedly in early talks to sell its homecare division, featuring brands like Air Wick and Calgon, as part of a broader strategy to focus on consumer health and hygiene. The sale... 
Via Benzinga
News headline image
Similac Baby Formula Maker Abbott And Reckitt Face Hundreds Of Baby Formula Lawsuits ↗
Abbott faces trial over claims its baby formula causes necrotizing enterocolitis in preterm infants. This is the second trial among hundreds of similar lawsuits, impacting Abbott and Reckitt... 
Via Benzinga
Topics Lawsuit
News headline image
What's Going On With Abbott Laboratories Stock On Friday? ↗
An Illinois jury orders Reckitt Benckiser's Mead Johnson to pay $60 million after a premature infant's tragic death linked to Enfamil baby formula. Mead Johnson found negligent for not warning about... 
Via Benzinga
Topics Lawsuit
News headline image
Durex Owner Reckitt Benckiser Taps Into China's Livestreaming Trend To Sell Condoms Online ↗
Reckitt Benckiser Group is leveraging the popularity of livestream shopping in China to sell condoms, a move that could be challenging due to strict regulatory oversight. 
Via Benzinga
News headline image
British Consumer Company Reckitt Benckiser's CEO Steps Down ↗
 
Via Benzinga
News headline image
FDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless - Stocks To Watch ↗
According to FDA panel experts who reviewed the latest research on the long-questioned phenylephrine, a drug ingredient used in several leading decongestants used by millions of Americans looking for... 
Via Benzinga
News headline image
Is There Collusion in the Baby-Formula Industry?: FTC Scrutinizes State Contracts Bidding Process ↗
 
Via Benzinga
News headline image
Reckitt Sees US Baby Food Formula Crisis Persisting Till Spring: Report ↗
 
Via Benzinga
News headline image
Baby Formula Startup Seeks To Compete Abbott With 15% Market Share: Report ↗
 
Via Benzinga
News headline image
Reckitt Lifts Annual Forecast On Higher Prices, Baby Formula Shortage ↗
 
Via Benzinga
News headline image
More Companies Join Race To Ease US Baby Formula Supply Crunch ↗
Danone SA (OTC: DANOY) has been doubling shipments to the U.S. of Neocate formula for infants allergic to cow's milk, while Enfamil maker Reckitt is also working to boost supplies amid a nationwide... 
Via Benzinga
News headline image
Danone Scales Up Baby Formula Shipments To US To Combat Shortage: Reuters ↗
Danone SA (OTC: DANOY) has stepped u 
Via Benzinga
News headline image
Morning Brief: Top Financial Stories Dominating on Friday, April 29 ↗
CNBC Hertz Chief Sees Business Travel Recovery Choking Already Strained Used Car Supply Hertz Global Holdings, Inc (NASDAQ: HTZ) chief Stephen Scherr saw a recovery in business... 
Via Benzinga
News headline image
Reckitt Benckiser Hikes Prices To Compensate For Falling Demand: FT ↗
Reckitt Benckiser Group Plc (OTC: RBGLY) (OTC: RBGPF) has hiked prices across its product range to pass an increase in raw material costs onto customers, the Financial... 
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.